Achieve Life Sciences, Inc. (ACHV): Price and Financial Metrics
ACHV Price/Volume Stats
| Current price | $4.30 | 52-week high | $5.98 |
| Prev. close | $4.34 | 52-week low | $3.03 |
| Day low | $4.25 | Volume | 74,900 |
| Day high | $4.38 | Avg. volume | 139,962 |
| 50-day MA | $4.72 | Dividend yield | N/A |
| 200-day MA | $4.66 | Market Cap | 147.88M |
ACHV Stock Price Chart Interactive Chart >
Achieve Life Sciences, Inc. (ACHV) Company Bio
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation aids in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.
ACHV Price Returns
| 1-mo | -12.07% |
| 3-mo | -4.66% |
| 6-mo | -20.52% |
| 1-year | -16.67% |
| 3-year | -43.42% |
| 5-year | -75.43% |
| YTD | 4.37% |
| 2023 | 68.16% |
| 2022 | -68.51% |
| 2021 | -3.95% |
| 2020 | -23.57% |
| 2019 | -56.21% |
Loading social stream, please wait...